Figure 2.

Representative western blot to analyze the protein expression of (A): nitric oxide synthase 2 (NOS2); (B): NADPH oxidase subunits, gp91‐, gp67‐ and gp47‐phox and (C): matrix metallopeptidase 9 (MMP9) in healthy aortic segments and aortic abdominal aneurysmal sites (AAA) incubated in the presence and in the absence of the FXa inhibitor, rivaroxaban (50 nmol l^–1). The expression of β‐actin was used as loading control